ArticleDiscover oncology2022

A Novel CTLA-4 affinity peptide for cancer immunotherapy by increasing the integrin αvβ3 targeting.

Ying Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.